Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Pulmonary artery

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44341   clinical trials with a EudraCT protocol, of which   7370   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    Study title: Use of imaging for assessing anatomical relationships of tracheo bronchial anomalies associated with left pulmonary artery sling; LEE KH; Pediatr. Radiol.; 2001 vol.31 p.269 278Use of imaging for assessing anatomical relationships of tracheo bronchial anomalies associated with left pulmonary artery sling; LEE KH; Pediatr. Radiol.; 2001 vol.31 p.269 278
    Active substance: IOVERSOL
    Study summary document link (including results):
    View full study record
    Document reference: 30435
    Study title: Bilateral pulmonary artery aneurysms in a patient with Behcet syndrome: evaluation with radionuclide angiography and V/Q lung scanning. Basoglu T, Canbaz F, Bernay I, Danaci M. Clin Nucl Med. 1998 Nov;23(11):735-8.
    Active substance: TECHNETIUM (99m)
    Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc
    View full study record
    Document reference: 48243
    Study title: Pulmonary perfusion after endovascular stenting of pulmonary artery stenosis. J Nucl Med. 1995 Nov;36(11):2006-8. Oyen WJ 2006
    Active substance: TECHNETIUM (99m)
    Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc
    View full study record
    Document reference: 48817
    Study title: Bilateral pulmonary artery aneurysms in a patient with Behcet syndrome: evaluation with radionuclide angiography and V/Q lung scanning. Clin Nucl Med. 1998 Nov;23(11):735-8. Basoglu T 1998
    Active substance: TECHNETIUM (99m)
    Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc
    View full study record
    Document reference: 48811
    Study title: Assessment of lung perfusion impairment in patients with pulmonary artery-occlusive and chronic obstructive pulmonary diseases with noncontrast electrocardiogram-gated fast-spin-echo perfusion MR imaging. J Magn Reson Imaging. 2004 Oct;20(4):601-11. Ogasawara N 2004
    Active substance: TECHNETIUM (99m)
    Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc
    View full study record
    Document reference: 48793
    Study title: Am J Cardiol. 1978 Oct;42(4):675-80. Thallium-201 myocardial imaging in anomalous left coronary artery arising from the pulmonary artery. Applications before and after medical and surgical treatment. Finley JP, Howman-Giles R, Gilday DL, Olley PM, Rowe Am J Cardiol. 1978 Oct;42(4):675-80. Thallium-201 myocardial imaging in anomalous left coronary artery arising from the pulmonary artery. Applications before and after medical and surgical treatment. Finley JP, Howman-Giles R, Gilday DL, Olley PM, Rowe
    Active substance: THALLIUM 201T1 CHLORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 44500
    Study title: Eur Heart J. 1990 Mar;11(3):213-8. Myocardial perfusion after aortic implantation for anomalous origin of the left coronary artery from the pulmonary artery. Seguchi M, Nakanishi T, Nakazawa M, Doi S, Momma K, Takao A, Imai Y, Kondoh C, Hiroe M. Eur Heart J. 1990 Mar;11(3):213-8. Myocardial perfusion after aortic implantation for anomalous origin of the left coronary artery from the pulmonary artery. Seguchi M, Nakanishi T, Nakazawa M, Doi S, Momma K, Takao A, Imai Y, Kondoh C, Hiroe M.
    Active substance: THALLIUM 201T1 CHLORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 44563
    Study title: J Pediatr. 1979 Feb;94(2):244-7. Thallium 201 scintigraphy in patients with anomalous origin of the left coronary artery from the main pulmonary artery. Rabinovitch M, Rowland TW, Castaneda AR, Treves S. J Pediatr. 1979 Feb;94(2):244-7. Thallium 201 scintigraphy in patients with anomalous origin of the left coronary artery from the main pulmonary artery. Rabinovitch M, Rowland TW, Castaneda AR, Treves S.
    Active substance: THALLIUM 201T1 CHLORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 44624
    Study title: Occult pulmonary artery. Confer R, Burke G, Robinson VJ. Clin Nucl Med. 1996 Dec;21(12):986-8.
    Active substance: TECHNETIUM (99m)
    Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc
    View full study record
    Document reference: 48249
    Study title: Pulmonary perfusion after endovascular stenting of pulmonary artery stenosis. Oyen WJ, van Oort AM, Tanke RB, van Mill GJ, Aengevaeren WR, Corstens FH. J Nucl Med. 1995 Nov;36(11):2006-8.
    Active substance: TECHNETIUM (99m)
    Study summary document link (including results): Oyen WJ 1995.pdf
    View full study record
    Document reference: 48259
    Study title: Unilateral ventilation--perfusion mismatch on pulmonary scintigraphy caused by anomalous origin of a pulmonary artery from the innominate artery. Hung GU, Tsai SC, Fu YC, Kao CH. Clin Nucl Med. 2001 Aug;26(8):719-20.
    Active substance: TECHNETIUM (99m)
    Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc
    View full study record
    Document reference: 48228
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Jun 05 22:57:56 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA